Clinical Trial Update: Prospective Evaluation of Adjusted Body Weight Dosing of Acyclovir in Obesity

View source ↗

Summary

A completed clinical trial evaluating adjusted body weight dosing of acyclovir in obesity to determine optimal dosing in obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ACYCLOVIR (Acyclovir)

Snippet

Sponsor: West Virginia University | Conditions: Obesity | Status: COMPLETED